GREG ROSE, President
Before starting CTG, Rose was General Manager of the Global Renal Therapy Business of Baxter International Inc. in Japan. Previously at Baxter he was Director of New Business Development for Baxter Limited (Japan), Manager of Business Planning for the Americas and Pacific Division (AMPAC), and Organization Planning Analyst in Baxter’s Corporate Human Resources Department.
Rose is presently Representative Director of ev3, K.K., and was previously Representative Director of ResMed, K.K., Aksys Japan, K.K., TherOx, K.K., Total Renal Care Japan, K.K., MediSense Japan, K.K., and Nova Viomedical, K.K., all of which he helped to establish and initially to manage.
Rose received his B.A., summa cum laude, from Wabash College where he was an Eli Lilly Scholar and member of Phi Beta Kappa. He received his M.A. in Economics from Vanderbilt University where he was a Harold Stirling Vanderbilt Fellow.
Rose is an active member of Tokyo Baptist Church where he previously served as Vice Chairman of the Finance and Properties Committee.